Biogen : BIIB

All Biogen Articles

606 Articles

Douglas A. McIntyre | Jan 17, 2008 at 7:09 AM EST

Top 10 Pre-Market Analyst Calls (ADBE, BIIB, DAI, DCGN, EBAY, HOG, JPM, WFC, MFE, MPEL, TIBX)

These are not at all the only key impact analyst calls, but these are the early bird calls that a673b.bigscoots-temp.com…

Douglas A. McIntyre | Jan 14, 2008 at 12:33 PM EST

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS…

Douglas A. McIntyre | Jan 7, 2008 at 8:32 AM EST

Top Pre-Market Stock News (January 7, 2008)

Below is a snapshot of some of the key impact news affecting stocks in pre-market trading this Monday, January 7,…

Douglas A. McIntyre | Dec 13, 2007 at 8:05 AM EST

Top 10 Pre-Market Analyst Calls (BIIB, BMC, COF, CLNE, FSLR, PLT, PMCS, RHT, SLM, WM)

There are many other analyst calls today, but these are the main calls we are looking at this morning: Biogen…

Douglas A. McIntyre | Dec 13, 2007 at 4:14 AM EST

Media Digest 12/13/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Paulson says that China is picking up the pace of the yuan rise. Reuters writesThe Asian Development…

Douglas A. McIntyre | Dec 12, 2007 at 4:44 PM EST

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen…

Douglas A. McIntyre | Dec 11, 2007 at 5:30 PM EST

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

Douglas A. McIntyre | Nov 20, 2007 at 8:05 AM EST

Pre-Market Stock News (November 20, 2007)

Biogen Idec (BIIB) announced an alliance with Neurimmune Therapeutics to develop treatments for Alzheimer’s Disease.BJ’s Wholesale (BJ) $0.35 EPS vs…

Douglas A. McIntyre | Oct 15, 2007 at 9:43 AM EDT

Carl Icahn Needs To Buy 4.9% Of Yahoo! (YHOO)

Carl Icahn has done a lot for shared holders at close to a dozen companies over the last year or…

Douglas A. McIntyre | Oct 13, 2007 at 8:40 AM EDT

Biogen Idec (BIIB) Puts Itself On The Block

Biotech firm Biogen Idec (BIIB) has put itself on the block, another victim of shareholder activist by Carl Icahn. The…

Douglas A. McIntyre | Oct 12, 2007 at 4:01 AM EDT

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

It seems that the thoughts of 24/7 Wall St. aren’t alone in the opinion of Amgen’s (NASDAQ:AMGN) future. In this…

Douglas A. McIntyre | Oct 2, 2007 at 6:42 AM EDT

Pre-Market Analyst Calls (October 2, 2007)

ACAD started as Hold at Citigroup.ALB raised to Neutral at Goldman Sachs.AMB raised to Buy at B of A.APD cut…

Douglas A. McIntyre | Sep 12, 2007 at 7:25 AM EDT

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a…

Douglas A. McIntyre | Sep 11, 2007 at 7:44 AM EDT

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

Amgen (NASDAQ:AMGN) has a huge day ahead of it. The biotech giant is presenting data today on the appropriateuse of…

1 … 38 39 40 41

Biogen : BIIB

All Biogen Articles

Top 10 Pre-Market Analyst Calls (ADBE, BIIB, DAI, DCGN, EBAY, HOG, JPM, WFC, MFE, MPEL, TIBX)

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Top Pre-Market Stock News (January 7, 2008)

Top 10 Pre-Market Analyst Calls (BIIB, BMC, COF, CLNE, FSLR, PLT, PMCS, RHT, SLM, WM)

Media Digest 12/13/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Pre-Market Stock News (November 20, 2007)

Carl Icahn Needs To Buy 4.9% Of Yahoo! (YHOO)

Biogen Idec (BIIB) Puts Itself On The Block

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

Pre-Market Analyst Calls (October 2, 2007)

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Biogen : BIIB

All Biogen Articles

Top 10 Pre-Market Analyst Calls (ADBE, BIIB, DAI, DCGN, EBAY, HOG, JPM, WFC, MFE, MPEL, TIBX)

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Top Pre-Market Stock News (January 7, 2008)

Top 10 Pre-Market Analyst Calls (BIIB, BMC, COF, CLNE, FSLR, PLT, PMCS, RHT, SLM, WM)

Media Digest 12/13/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Pre-Market Stock News (November 20, 2007)

Carl Icahn Needs To Buy 4.9% Of Yahoo! (YHOO)

Biogen Idec (BIIB) Puts Itself On The Block

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

Pre-Market Analyst Calls (October 2, 2007)

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s